Phase II AK Study in Organ Transplant Patients

NCT00829192 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratoses
Carcinoma, Squamous Cell
Organ Transplant Recipients

Interventions

DRUG: Afamelanotide (CUV1647)
DRUG: Placebo

Sponsor

Clinuvel Pharmaceuticals Limited